Literature DB >> 7379450

Rifampicin and vitamin D metabolism.

M J Brodie, A R Boobis, C T Dollery, C J Hillyard, D J Brown, I MacIntyre, B K Park.   

Abstract

A 2-wk course of rifampicin orally (600 mg/day) in 8 male subjects resulted in a consistent fall in plasma 25-hydroxycholecalciferol (25-OHD) levels of around 70%, accompanied by increased oxidation of antipyrine and 6 beta-hydroxycortisol (indicative of hepatic enzyme induction). Plasma levels of 1,25-dihydroxycholecalciferol, parathyroid hormone, and calcitonin were not altered. The fall in 25-OHD may represent the earliest lesion of drug-induced osteomalacia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7379450     DOI: 10.1038/clpt.1980.115

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  39 in total

Review 1.  Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches.

Authors:  Gaëlle Magliocco; Aurélien Thomas; Jules Desmeules; Youssef Daali
Journal:  Clin Pharmacokinet       Date:  2019-11       Impact factor: 6.447

2.  Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects.

Authors:  E Perucca; R Grimaldi; G M Frigo; A Sardi; H Mönig; E E Ohnhaus
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Remission of hypercalciuria in patients with tuberculosis after treatment.

Authors:  M E Martinez; J Gonzalez; M J Sanchez-Cabezudo; J M Peña; J J Vazquez
Journal:  Calcif Tissue Int       Date:  1996-07       Impact factor: 4.333

4.  Recurrent symptomatic hypocalcemia during rifampicin therapy for brucellosis.

Authors:  Ayse Nur Torun; Mehmet Ali Eren; Mehmet Demir; Tevfik Sabuncu
Journal:  Wien Klin Wochenschr       Date:  2011-07-07       Impact factor: 1.704

Review 5.  Clinical implications of enzyme induction and enzyme inhibition.

Authors:  B K Park; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

6.  Effect of rifampicin on haem and bilirubin metabolism in man.

Authors:  K E McColl; G G Thompson; E el Omar; M R Moore; B K Park; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

7.  An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

Authors:  Zhican Wang; Yvonne S Lin; Xi Emily Zheng; Tauri Senn; Takanori Hashizume; Michele Scian; Leslie J Dickmann; Sidney D Nelson; Thomas A Baillie; Mary F Hebert; David Blough; Connie L Davis; Kenneth E Thummel
Journal:  Mol Pharmacol       Date:  2011-12-28       Impact factor: 4.436

8.  Parathyroid carcinoma associated with chronic renal failure and previous radiotherapy to the neck.

Authors:  J P Ireland; S J Fleming; D A Levison; W R Cattell; L R Baker
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

9.  Total body calcium mass in primary hyperparathyroidism and long-term changes.

Authors:  L E Jimenez; T J Spinks; A S Ranicar; G F Joplin
Journal:  Calcif Tissue Int       Date:  1984-01       Impact factor: 4.333

Review 10.  The pregnane X receptor: from bench to bedside.

Authors:  Xiaochao Ma; Jeffrey R Idle; Frank J Gonzalez
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-07       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.